Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
UBS Group AG has become a substantial holder of Australian Clinical Labs Ltd, acquiring a 6.21% voting power through various branches and subsidiaries. This move involves over 12.5 million ordinary shares, highlighting UBS’s strategic interest in the company. Investors may find this development noteworthy as it reflects a significant financial stake by a major global player.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.